Population
Pregnant women at risk of or with suspected/established venous thromboembolism
Design
Review
Authors
Loading...
LMWH preference for pregnancy VTE may inform current choices; leaves open need for RCTs on dosing and outcomes.
Low-molecular-weight heparins are highlighted as the preferred agents for managing venous thromboembolism in pregnancy due to the fetal risks of warfarin and maternal risks of unfractionated heparin.
Ian A. Greer (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: